This Review addresses various strategies to manipulate FcR function to overcome immune complex-mediated inflammatory diseases, and considers approaches to improve antibody-based anticancer therapies.
Hogarth, P. M., & Pietersz, G. A. (2012). Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nature Reviews Drug Discovery, 11(4), 311 - 331. https://doi.org/10.1038/nrd2909